Selected research
Market Outlook & Growth Opportunities
Global Immunology Testing Services Market Outlook and Growth Opportunities 2026
Market perspective
The global Immunology Testing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Immunology Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Immunology Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Immunology Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Immunology Testing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Immunology Testing Services market include KMD Biotechnology (Tianjin) Co., Ltd., Certimmune, Charles River Laboratories, EpiVax, Viroclinics Biosciences, SYNLAB, ICON plc, Qingdao Kechuang Quality Inspection Co., Ltd. and Standard Testing Group Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Immunology Testing Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Immunology Testing Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Immunology Testing Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Immunology Testing Services market.
Immunology Testing Services Segment by Company
KMD Biotechnology (Tianjin) Co., Ltd.
Certimmune
Charles River Laboratories
EpiVax
Viroclinics Biosciences
SYNLAB
ICON plc
Qingdao Kechuang Quality Inspection Co., Ltd.
Standard Testing Group Co., Ltd.
Nanjing Keyi Biotechnology Co., Ltd.
Immunology Testing Services Segment by Type
Antibody Detection
autoantibody Detection
Immune Cell Detection
Immunohistochemical detection
Others
Immunology Testing Services Segment by Application
Medical Industry
Environmental Industry
Agriculture
Immunology Testing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Immunology Testing Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Immunology Testing Services key companies, revenue, market share, and recent developments.
3. To split the Immunology Testing Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Immunology Testing Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Immunology Testing Services significant trends, drivers, influence factors in global and regions.
6. To analyze Immunology Testing Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunology Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immunology Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunology Testing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immunology Testing Services industry.
Chapter 3: Detailed analysis of Immunology Testing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Immunology Testing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Immunology Testing Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Antibody Detection
- autoantibody Detection
- Immune Cell Detection
- Immunohistochemical detection
- Others
Applications
- Medical Industry
- Environmental Industry
- Agriculture
Companies covered
- KMD Biotechnology (Tianjin) Co., Ltd.
- Certimmune
- Charles River Laboratories
- EpiVax
- Viroclinics Biosciences
- SYNLAB
- ICON plc
- Qingdao Kechuang Quality Inspection Co., Ltd.
- Standard Testing Group Co., Ltd.
- Nanjing Keyi Biotechnology Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Immunology Testing Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Immunology Testing Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Immunology Testing Services Market Dynamics
- 2.1 Immunology Testing Services Industry Trends
- 2.2 Immunology Testing Services Industry Drivers
- 2.3 Immunology Testing Services Industry Opportunities and Challenges
- 2.4 Immunology Testing Services Industry Restraints
3 Immunology Testing Services Market by Company
- 3.1 Global Immunology Testing Services Company Revenue Ranking in 2025
- 3.2 Global Immunology Testing Services Revenue by Company (2021-2026)
- 3.3 Global Immunology Testing Services Company Ranking (2024-2026)
- 3.4 Global Immunology Testing Services Company Manufacturing Base and Headquarters
- 3.5 Global Immunology Testing Services Company Product Type and Application
- 3.6 Global Immunology Testing Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Immunology Testing Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Immunology Testing Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Immunology Testing Services Market by Type
- 4.1 Immunology Testing Services Type Introduction
- 4.1.1 Antibody Detection
- 4.1.2 autoantibody Detection
- 4.1.3 Immune Cell Detection
- 4.1.4 Immunohistochemical detection
- 4.1.5 Others
- 4.2 Global Immunology Testing Services Sales Value by Type
- 4.2.1 Global Immunology Testing Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Immunology Testing Services Sales Value by Type (2021-2032)
- 4.2.3 Global Immunology Testing Services Sales Value Share by Type (2021-2032)
5 Immunology Testing Services Market by Application
- 5.1 Immunology Testing Services Application Introduction
- 5.1.1 Medical Industry
- 5.1.2 Environmental Industry
- 5.1.3 Agriculture
- 5.2 Global Immunology Testing Services Sales Value by Application
- 5.2.1 Global Immunology Testing Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Immunology Testing Services Sales Value by Application (2021-2032)
- 5.2.3 Global Immunology Testing Services Sales Value Share by Application (2021-2032)
6 Immunology Testing Services Regional Value Analysis
- 6.1 Global Immunology Testing Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Immunology Testing Services Sales Value by Region (2021-2032)
- 6.2.1 Global Immunology Testing Services Sales Value by Region: 2021-2026
- 6.2.2 Global Immunology Testing Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Immunology Testing Services Sales Value (2021-2032)
- 6.3.2 North America Immunology Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Immunology Testing Services Sales Value (2021-2032)
- 6.4.2 Europe Immunology Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Immunology Testing Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Immunology Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Immunology Testing Services Sales Value (2021-2032)
- 6.6.2 South America Immunology Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Immunology Testing Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Immunology Testing Services Sales Value Share by Country, 2025 VS 2032
7 Immunology Testing Services Country-level Value Analysis
- 7.1 Global Immunology Testing Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Immunology Testing Services Sales Value by Country (2021-2032)
- 7.2.1 Global Immunology Testing Services Sales Value by Country (2021-2026)
- 7.2.2 Global Immunology Testing Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Immunology Testing Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Immunology Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Immunology Testing Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 KMD Biotechnology (Tianjin) Co., Ltd.
- 8.1.1 KMD Biotechnology (Tianjin) Co., Ltd. Company Information
- 8.1.2 KMD Biotechnology (Tianjin) Co., Ltd. Business Overview
- 8.1.3 KMD Biotechnology (Tianjin) Co., Ltd. Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 8.1.4 KMD Biotechnology (Tianjin) Co., Ltd. Immunology Testing Services Product Portfolio
- 8.1.5 KMD Biotechnology (Tianjin) Co., Ltd. Recent Developments
- 8.2 Certimmune
- 8.2.1 Certimmune Company Information
- 8.2.2 Certimmune Business Overview
- 8.2.3 Certimmune Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 8.2.4 Certimmune Immunology Testing Services Product Portfolio
- 8.2.5 Certimmune Recent Developments
- 8.3 Charles River Laboratories
- 8.3.1 Charles River Laboratories Company Information
- 8.3.2 Charles River Laboratories Business Overview
- 8.3.3 Charles River Laboratories Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 8.3.4 Charles River Laboratories Immunology Testing Services Product Portfolio
- 8.3.5 Charles River Laboratories Recent Developments
- 8.4 EpiVax
- 8.4.1 EpiVax Company Information
- 8.4.2 EpiVax Business Overview
- 8.4.3 EpiVax Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 8.4.4 EpiVax Immunology Testing Services Product Portfolio
- 8.4.5 EpiVax Recent Developments
- 8.5 Viroclinics Biosciences
- 8.5.1 Viroclinics Biosciences Company Information
- 8.5.2 Viroclinics Biosciences Business Overview
- 8.5.3 Viroclinics Biosciences Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 8.5.4 Viroclinics Biosciences Immunology Testing Services Product Portfolio
- 8.5.5 Viroclinics Biosciences Recent Developments
- 8.6 SYNLAB
- 8.6.1 SYNLAB Company Information
- 8.6.2 SYNLAB Business Overview
- 8.6.3 SYNLAB Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 8.6.4 SYNLAB Immunology Testing Services Product Portfolio
- 8.6.5 SYNLAB Recent Developments
- 8.7 ICON plc
- 8.7.1 ICON plc Company Information
- 8.7.2 ICON plc Business Overview
- 8.7.3 ICON plc Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 8.7.4 ICON plc Immunology Testing Services Product Portfolio
- 8.7.5 ICON plc Recent Developments
- 8.8 Qingdao Kechuang Quality Inspection Co., Ltd.
- 8.8.1 Qingdao Kechuang Quality Inspection Co., Ltd. Company Information
- 8.8.2 Qingdao Kechuang Quality Inspection Co., Ltd. Business Overview
- 8.8.3 Qingdao Kechuang Quality Inspection Co., Ltd. Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 8.8.4 Qingdao Kechuang Quality Inspection Co., Ltd. Immunology Testing Services Product Portfolio
- 8.8.5 Qingdao Kechuang Quality Inspection Co., Ltd. Recent Developments
- 8.9 Standard Testing Group Co., Ltd.
- 8.9.1 Standard Testing Group Co., Ltd. Company Information
- 8.9.2 Standard Testing Group Co., Ltd. Business Overview
- 8.9.3 Standard Testing Group Co., Ltd. Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 8.9.4 Standard Testing Group Co., Ltd. Immunology Testing Services Product Portfolio
- 8.9.5 Standard Testing Group Co., Ltd. Recent Developments
- 8.10 Nanjing Keyi Biotechnology Co., Ltd.
- 8.10.1 Nanjing Keyi Biotechnology Co., Ltd. Company Information
- 8.10.2 Nanjing Keyi Biotechnology Co., Ltd. Business Overview
- 8.10.3 Nanjing Keyi Biotechnology Co., Ltd. Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 8.10.4 Nanjing Keyi Biotechnology Co., Ltd. Immunology Testing Services Product Portfolio
- 8.10.5 Nanjing Keyi Biotechnology Co., Ltd. Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst